| Term 
 | Definition 
 
        | blockers of beta 1: increase heart rate increase contractility; increase renin release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta 2 blocker cause relaxation of vascular bronchial and uterine smooth muscle ; increase glycogenolysis; increase insulin release; increase tremor **** bronchial**** and ****uterine smooth muscle*** |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blockers of beta 3 increase lipolysis increase urinary bladder relaxation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha 1 blockers cause vasoconstriction, mydriasis ( pupil dialation) , piloerection( hair standing up) and increase in glycogenolysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decrease neuronal transmitter release, increase platelete aggregation, decrease lipolysis decrease insulin release |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antagonize (block) the B1 and B2 receptors Decrease heart rate
 Decrease contractility
 Decrease renin release (decrease angiotensin II)
 |  | 
        |  | 
        
        | Term 
 
        | Mechanisms specific to heart failure |  | Definition 
 
        | Restore heart rate variability( patients see a big difference in resting heart rate) Prevent arrhythmia occurrence
 Prevent/slow remodeling process (hypertrophy)
 Inhibit renin secretion
 
 NE still in heart in MI
 patients need to be advised that effects are bad at first but get better over time
 |  | 
        |  | 
        
        | Term 
 
        | Beta blockers place in therapy |  | Definition 
 
        | Have long been considered one of drugs of choice for initial therapy Recent data shows less of a stroke benefit than other classes; clinically important increase in new diabetes
 No longer liked for hyper tension PB because it increases diabetes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gold standard for heart failure (and post-MI) Symptoms will worsen initially, but slow improvement
 Slow titration:  3.125-6.25-12.5-25-50  or  12.5-25-50-100-200 ( push until you see side effects stop)
 Target dosing shown to be effective **** Important because Heart failure if you dont have target dose*****
 
 High blood pressure use low dose until HPB comes in line *****exercise intolerance*****
 |  | 
        |  | 
        
        | Term 
 
        | Beta blockers remaining questions |  | Definition 
 
        | Remaining questions: Role in therapy?  ... younger patients, HF risk, angina
 What about newer beta-blockers?
 **** you cant rely on symptoms because all patients will feel worse initially*****
 |  | 
        |  | 
        
        | Term 
 
        | Selective Agents Metoprolol
 Atenolol
 Bisoprolol
 Betaxolol
 Nebivolol
 Acebutolol
 Esmolol
 |  | Definition 
 
        | beta 1 most important group, selective cardio affinity for beta 1 receptor --good for pulmonary effect---Relatively selective especially in big doses ---dont give to people with COPD---Mild to high dose will show bronchial effect |  | 
        |  | 
        
        | Term 
 
        | Intrinsic Sympathomimetic Activity (ISA) |  | Definition 
 
        | Pindolol Acebutolol
 Mimic sympathetic partially NO HF NO NO ANGINA
 Beneficial decreased side effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Carvedilol (alpha1-antagonist)***in addition to blocking alpha it also blocks beta**** Nebivolol (increased NO)
 Labetolol (alpha1-antagonist)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibit transmembrane influx of calcium Act at SA/AV node &/or vascular smooth muscle
 Vasodilation &/or Decreased heart rate
 
 Other effects specific to class
 ***2main groups**
 Diltiazem and Verapamil (very limited)
 Negative inotropic and chronotropic effects
 
 Dihydropyridines
 No effects on conduction in vivo
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks entry into cell and is essential for muscle contraction**** works by relaxing the vascular muscle |  | 
        |  | 
        
        | Term 
 
        | Calcium channel blockers group1 |  | Definition 
 
        | Verapamil Diltiazem stronger on heart vascular |  | 
        |  | 
        
        | Term 
 
        | calcium channel blockers group 2 |  | Definition 
 
        | dihydropyridines (DHP)do nothing on heart but great on vasodilation |  | 
        |  | 
        
        | Term 
 
        | Calcium Channel BlockersCommon Adverse Effects |  | Definition 
 
        | Headache ***brain does not like** Flushing ***vasodilating**
 Pedal edema***especially dependent edema- common with DHP***
 Constipation*****verapamil***
 Hypotension ***both**
 Reflex tachycardia ***more with DHP***
 Bradycardia, AV Block, CHF ********effects heart---hint verapamil & diltiazem******* said as a reminder
 |  | 
        |  | 
        
        | Term 
 
        | Calcium Channel Blockers Drug Interactions |  | Definition 
 
        | Verapamil and Diltiazem ***can directly slow enzymes that effect other drugs*** Can cause many drug interactions
 Change metabolism and/or transport of drugs
 
 Nifedipine, Felodipine, others
 Subject of many interactions
 Sensitive to changes caused by other drugs
 ******victims and perpetrators *******
 |  | 
        |  |